{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:04:35Z","timestamp":1785495875741,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Scientific Research Projects of Wuhan Municipal Health Commission","award":["WX23Z02"],"award-info":[{"award-number":["WX23Z02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10096-025-05119-3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:49:13Z","timestamp":1743828553000},"page":"1433-1442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Early appropriate therapy with polymyxin B reduces the mortality in burn sepsis caused by carbapenem-resistant gram-negative bacteria: a retrospective analysis"],"prefix":"10.1007","volume":"44","author":[{"given":"Nanhong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"5119_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41038-017-0089-5","volume":"5","author":"DG Greenhalgh","year":"2017","unstructured":"Greenhalgh DG (2017) Sepsis in the burn patient: a different problem than sepsis in the general population. Burns Trauma 5:23. https:\/\/doi.org\/10.1186\/s41038-017-0089-5","journal-title":"Burns Trauma"},{"key":"5119_CR2","doi-asserted-by":"publisher","first-page":"tkaa047","DOI":"10.1093\/burnst\/tkaa047","volume":"9","author":"P Zhang","year":"2021","unstructured":"Zhang P, Zou B, Liou YC, Huang C (2021) The pathogenesis and diagnosis of sepsis post burn injury. Burns Trauma 9:tkaa047. https:\/\/doi.org\/10.1093\/burnst\/tkaa047","journal-title":"Burns Trauma"},{"issue":"2","key":"5119_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1089\/sur.2017.288","volume":"19","author":"M Stanojcic","year":"2018","unstructured":"Stanojcic M, Vinaik R, Jeschke MG (2018) Status and challenges of predicting and diagnosing sepsis in burn patients. Surg Infect 19(2):168\u2013175. https:\/\/doi.org\/10.1089\/sur.2017.288","journal-title":"Surg Infect"},{"issue":"1","key":"5119_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/sur.2020.348","volume":"22","author":"MJM Torres","year":"2021","unstructured":"Torres MJM, Peterson JM, Wolf SE (2021) Detection of infection and sepsis in burns. Surg Infect (Larchmt) 22(1):20\u201327. https:\/\/doi.org\/10.1089\/sur.2020.348","journal-title":"Surg Infect (Larchmt)"},{"key":"5119_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/TCRM.S119938","volume":"13","author":"O Nunez Lopez","year":"2017","unstructured":"Nunez Lopez O, Cambiaso-Daniel J, Branski LK, Norbury WB, Herndon DN (2017) Predicting and managing sepsis in burn patients: current perspectives. Ther Clin Risk Manag 13:1107\u20131117. https:\/\/doi.org\/10.2147\/TCRM.S119938","journal-title":"Ther Clin Risk Manag"},{"key":"5119_CR6","doi-asserted-by":"publisher","first-page":"1109418","DOI":"10.3389\/fcimb.2023.1109418","volume":"13","author":"Q Liao","year":"2023","unstructured":"Liao Q, Feng Z, Lin H et al (2023) Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development. Front Cell Infect Microbiol 13:1109418. https:\/\/doi.org\/10.3389\/fcimb.2023.1109418","journal-title":"Front Cell Infect Microbiol"},{"key":"5119_CR7","doi-asserted-by":"publisher","unstructured":"Doi Y (2019) Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis 69(Suppl 7):S565\u2013S575. https:\/\/doi.org\/10.1093\/cid\/ciz830","DOI":"10.1093\/cid\/ciz830"},{"issue":"1","key":"5119_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13054-023-04522-6","volume":"27","author":"S Liu","year":"2023","unstructured":"Liu S, Wu Y, Qi S et al (2023) Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial. Crit Care 27(1):232. https:\/\/doi.org\/10.1186\/s13054-023-04522-6","journal-title":"Crit Care"},{"issue":"6","key":"5119_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/BCR.0b013e3181599bc9","volume":"28","author":"DG Greenhalgh","year":"2007","unstructured":"Greenhalgh DG, Saffle JR, Holmes JHT et al (2007) American burn association consensus conference to define sepsis and infection in burns. J Burn Care Res 28(6):776\u201390. https:\/\/doi.org\/10.1097\/BCR.0b013e3181599bc9","journal-title":"J Burn Care Res"},{"key":"5119_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/IDR.S294282","volume":"14","author":"C Zhou","year":"2021","unstructured":"Zhou C, Jin L, Wang Q et al (2021) Bloodstream infections caused by carbapenem-resistant enterobacterales: risk factors for mortality, antimicrobial therapy and treatment outcomes from a prospective multicenter study. Infect Drug Resist 14:731\u2013742. https:\/\/doi.org\/10.2147\/IDR.S294282","journal-title":"Infect Drug Resist"},{"issue":"7","key":"5119_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","volume":"17","author":"B Gutierrez-Gutierrez","year":"2017","unstructured":"Gutierrez-Gutierrez B, Salamanca E, de Cueto M et al (2017) Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis 17(7):726\u2013734. https:\/\/doi.org\/10.1016\/S1473-3099(17)30228-1","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5119_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, Group KAGW (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17(1):204. https:\/\/doi.org\/10.1186\/cc11454","journal-title":"Crit Care"},{"issue":"4","key":"5119_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/EJA.0000000000000595","volume":"34","author":"I Martin-Loeches","year":"2017","unstructured":"Martin-Loeches I, Leone M, Mad\u00e1ch K, Martin C, Einav S (2017) Antibiotic therapy in the critically ill - expert opinion of the Intensive care medicine scientific subcommittee of the european society of anaesthesiology. Eur J Anaesthesiol 34(4):215\u2013220. https:\/\/doi.org\/10.1097\/EJA.0000000000000595","journal-title":"Eur J Anaesthesiol"},{"issue":"11","key":"5119_CR14","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1128\/AAC.00627-10","volume":"54","author":"M Paul","year":"2010","unstructured":"Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L (2010) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54(11):4851\u20134863. https:\/\/doi.org\/10.1128\/AAC.00627-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5119_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bjid.2018.12.004","volume":"23","author":"Q Liang","year":"2019","unstructured":"Liang Q, Huang M, Xu Z (2019) Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Braz J Infect Dis 23(1):60\u201365. https:\/\/doi.org\/10.1016\/j.bjid.2018.12.004","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"5119_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13756-022-01103-0","volume":"11","author":"Q Liang","year":"2022","unstructured":"Liang Q, Chen J, Xu Y, Chen Y, Huang M (2022) Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study. Antimicrob Resist Infect Control 11(1):89. https:\/\/doi.org\/10.1186\/s13756-022-01103-0","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7","key":"5119_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.burns.2023.05.003","volume":"49","author":"DG Greenhalgh","year":"2023","unstructured":"Greenhalgh DG, Hill DM, Burmeister DM et al (2023) Surviving sepsis after burn campaign. Burns 49(7):1487\u20131524. https:\/\/doi.org\/10.1016\/j.burns.2023.05.003","journal-title":"Burns"},{"issue":"1","key":"5119_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13054-023-04448-z","volume":"27","author":"T Tang","year":"2023","unstructured":"Tang T, Li Y, Xu P et al (2023) Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study. Critical Care 27(1):164. https:\/\/doi.org\/10.1186\/s13054-023-04448-z","journal-title":"Critical Care"},{"issue":"1","key":"5119_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"BT Tsuji","year":"2019","unstructured":"Tsuji BT, Pogue JM, Zavascki AP et al (2019) International consensus guidelines for the optimal use of polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical microbiology and infectious diseases (ESCMID), infectious diseases society of America (IDSA), international society for anti-infective pharmacology (ISAP), society of critical care medicine (SCCM), and society of infectious diseases pharmacists (SIDP). Pharmacotherapy 39(1):10\u201339. https:\/\/doi.org\/10.1002\/phar.2209","journal-title":"Pharmacotherapy"},{"key":"5119_CR20","doi-asserted-by":"publisher","unstructured":"Miglis C, Rhodes NJ, Avedissian SN et al (2018) Population Pharmacokinetics of Polymyxin B in acutely ill adult patients. Antimicrob Agents Chemother 62(3). https:\/\/doi.org\/10.1128\/AAC.01475-17","DOI":"10.1128\/AAC.01475-17"},{"key":"5119_CR21","doi-asserted-by":"publisher","first-page":"754844","DOI":"10.3389\/fphar.2021.754844","volume":"12","author":"P Wang","year":"2021","unstructured":"Wang P, Zhang Q, Feng M, Sun T, Yang J, Zhang X (2021) Population pharmacokinetics of Polymyxin B in obese patients for resistant gram-negative infections. Front Pharmacol 12:754844. https:\/\/doi.org\/10.3389\/fphar.2021.754844","journal-title":"Front Pharmacol"},{"issue":"1","key":"5119_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13054-023-04448-z","volume":"27","author":"T Tang","year":"2023","unstructured":"Tang T, Li Y, Xu P et al (2023) Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study. Critical Care 27(1):164. https:\/\/doi.org\/10.1186\/s13054-023-04448-z","journal-title":"Critical Care"},{"key":"5119_CR23","doi-asserted-by":"publisher","first-page":"103292","DOI":"10.1016\/j.iccn.2022.103292","volume":"73","author":"XYD Tan","year":"2022","unstructured":"Tan XYD, Wiseman T, Betihavas V (2022) Risk factors for nosocomial infections and\/or sepsis in adult burn patients: an integrative review. Intensive Crit Care Nurs 73:103292. https:\/\/doi.org\/10.1016\/j.iccn.2022.103292","journal-title":"Intensive Crit Care Nurs"},{"key":"5119_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.hrtlng.2024.11.020","volume":"70","author":"L Sun","year":"2025","unstructured":"Sun L, Zhang C, Song P et al (2025) Hypertension and 28-day mortality in sepsis patients: an observational and mendelian randomization study. Heart Lung: J Crit Care 70:147\u2013156. https:\/\/doi.org\/10.1016\/j.hrtlng.2024.11.020","journal-title":"Heart Lung: J Crit Care"},{"issue":"1","key":"5119_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13054-017-1609-1","volume":"21","author":"HJ de Grooth","year":"2017","unstructured":"de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM (2017) SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care 21(1):38. https:\/\/doi.org\/10.1186\/s13054-017-1609-1","journal-title":"Crit Care"},{"issue":"1","key":"5119_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.burns.2022.09.004","volume":"49","author":"J Calles","year":"2023","unstructured":"Calles J, Cohen B, Forme N, Guendil Z, Fermier B, Chassier C et al (2023) Variation of the sofa score and mortality in patients with severe burns: a cohort study. Burns 49(1):34\u201341. https:\/\/doi.org\/10.1016\/j.burns.2022.09.004","journal-title":"Burns"},{"issue":"5","key":"5119_CR27","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/jac\/dku561","volume":"70","author":"MH Rigatto","year":"2015","unstructured":"Rigatto MH, Behle TF, Falci DR et al (2015) Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study. J Antimicrob Chemother 70(5):1552\u20131557. https:\/\/doi.org\/10.1093\/jac\/dku561","journal-title":"J Antimicrob Chemother"},{"issue":"20","key":"5119_CR28","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.21037\/atm-22-4959","volume":"10","author":"J Jin","year":"2022","unstructured":"Jin J, Zhu J, Zhu Z et al (2022) Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study. Ann Transl Med 10(20):1137. https:\/\/doi.org\/10.21037\/atm-22-4959","journal-title":"Ann Transl Med"},{"key":"5119_CR29","doi-asserted-by":"publisher","first-page":"672543","DOI":"10.3389\/fphar.2022.672543","volume":"13","author":"XL Wu","year":"2022","unstructured":"Wu XL, Long WM, Lu Q et al (2022) Polymyxin B-associated nephrotoxicity and its predictors: a retrospective study in carbapenem-resistant gram-negative bacterial infections. Front Pharmacol 13:672543. https:\/\/doi.org\/10.3389\/fphar.2022.672543","journal-title":"Front Pharmacol"},{"issue":"5","key":"5119_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/ph13050083","volume":"13","author":"NV Dubashynskaya","year":"2020","unstructured":"Dubashynskaya NV, Skorik YA (2020) Polymyxin Delivery Systems: Recent Advances and Challenges. Pharmaceuticals (Basel) 13(5):83. https:\/\/doi.org\/10.3390\/ph13050083","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05119-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05119-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:57:16Z","timestamp":1748350636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05119-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5119"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05119-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received IRB approval from the Human Research Ethics Committee of Tongren Hospital of Wuhan University (Wuhan Third Hospital) (No.KY2023-023). Considering the study's retrospective design, the need for informed consent was not applicable and thus waived. It is important to note that all methods employed in this study were conducted in adherence to applicable guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}